Buscar
Mostrando ítems 1-10 de 281
Point-of-care diagnostic tests for low-resource settings
(Elsevier, 2015)
Point-of-care diagnostic tests (POCTs) can enable health-care workers to provide more rapid and effective care to people in low-resource settings.1 POCTs should ideally meet the WHO's ASSURED criteria2—ie, being affordable, ...
An outlook on electrochemical approaches for molecular diagnostics assays and discussions on the limitations of miniaturized technologies for point-of-care devices
(2022-11-01)
The detection of specific biomarkers for health monitoring, i.e., molecular diagnostics, can be classified as early or emergency diagnostics. Emergency diagnostics is related to those diseases which is necessary a rapid ...
Serological point-of-care and label-free capacitive diagnosis of dengue virus infection
(2020-03-01)
Dengue non-structural protein 1 (NS1 DENV) is considered a biomarker for dengue fever in an early stage. A sensitive and rapid assay for distinguishing positive from negative dengue infection samples is imperative for ...
Potential point of care tests (POCTs) for maternal health in Peru, perspectives of pregnant women and their partners
(BMC, 2014)
Background: Globally, no qualitative studies have explored the perspectives of women and their partners about the integration of technology – and specifically diagnostic testing technologies – into antenatal care. The study ...
Perspectives on and Precautions for the Uses of Electric Spectroscopic Methods in Label-free Biosensing Applications
(2019-01-01)
Label-free approaches for molecular diagnostic applications are appealing because of their inherent point-of-care advantages. Nonetheless, technical challenges impose a limit on the use of these methods as will be discussed ...
Molecular diagnostic technologies for COVID-19: Limitations and challenges
To curb the spread of COVID-19 (coronavirus disease 2019) pandemic, the world needs diagnostic
systems capable of rapid detection and quantification of the novel coronavirus (SARS-CoV-2). Many
biomedical companies are ...
Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles
(Public Library of Science, 2017)
The global prevalence of malaria has decreased over the past fifteen years, but similar gains have not been realized against Plasmodium vivax because this species is less responsive to conventional malaria control interventions ...
SARS-CoV, MERS-CoV and SARS-CoV-2: a diagnostic challenge
(Elsevier, 2020)
Performance of BinaxNOW G6PD deficiency point-of-care diagnostic in P vivax-infected subjects
(American Society of Tropical Medicine and Hygiene, 2015)
Accurate diagnosis of glucose-6-phosphate dehydrogenase (G6PD) deficiency is required to avoid the risk of acute hemolysis associated with 8-aminoquinoline treatment. The performance of the BinaxNOW G6PD test compared with ...
Evaluation of a point-of-care molecular detection device for Leishmania spp. and intercurrent fungal and mycobacterial organisms in Peruvian patients with cutaneous ulcers
(Springer, 2021)
PURPOSE: Overlapping clinical features of cutaneous leishmaniasis (CL) with ulcers caused by fungi and mycobacteria necessitate confirmatory diagnostic testing. We evaluated a handheld battery-operated device for detection ...